QR Code

Effect of Empagliflozin on Whole Body, Cardiac, and Renal Sympathetic Outflows in Type 2 Diabetes

Background: Sodium glucose co-transporter type 2 inhibitors improve cardiovascular outcomes in people with type 2 diabetes, though mechanisms by which this occurs remain unclear. Objectives: The purpose of this study was to evaluate empagliflozin’s effect on whole body, cardiac, and renal sympatheti...

Full description

Saved in:
Main Authors: Anne T. Reutens, MBBS, PhD, FRACP, Dulari Hakamuwa Lekamlage, PhD, Agus Salim, PhD, Jonathan E. Shaw, MBChB, MD, FRCP (UK), FRACP, FAAHMS, Murray D. Esler, MBBS, PhD, FRACP, Mark E. Cooper, MBBS, PhD, David M. Kaye, MBBS, PhD, FRACP
Format: Artigo
Language:Inglês
Published: Elsevier 2025-12-01
Series:JACC: Advances
Subjects:
empagliflozin
hemodynamics
norepinephrine spillover kinetics right heart catheter
SGLT2 inhibitor
sympathetic nervous activity
Online Access:http://www.sciencedirect.com/science/article/pii/S2772963X25007331
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items